title: [Kidney and bone update : the 5-year history and future of CKD-MBD. About the guideline of the Japanese Society for Dialysis Therapy].
abstract: Disturbances in mineral and bone metabolism are prevalent in chronic kidney disease (CKD) and are an important cause of morbidity, decreased quality of life Accordingly, instead of the classic term "Renal Osteodystrophy (ROD) " , a new term, "CKD-Mineral and Bone Disorders (CKD-MBD) " , has been proposed as a systemic disorder. In 2012, new Japanese Society for Dialysis Therapy (JSDT) clinical practice guideline for CKD-MBD is intended to assist the practitioner caring for adults and children with CKD stages 3-5, on HD therapy, on PD therapy or with a kidney transplant.
authors: Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, Japan.
authors: Keitaro
authors: K
authors: Yokoyama
mesh_terms: D000328:Adult; D001842:Bone and Bones / Q000378:metabolism; D002118:Calcium / Q000097:blood; D002648:Child; D002908:Chronic Disease; D012080:Chronic Kidney Disease-Mineral and Bone Disorder / Q000097:blood / Q000209:etiology / Q000378:metabolism / Q000503:physiopathology / Q000628:therapy*; D003956:Dialysis / Q000009:adverse effects; D006801:Humans; D007564:Japan; D007674:Kidney Diseases / Q000150:complications / Q000378:metabolism / Q000503:physiopathology / Q000628:therapy*; D010280:Parathyroid Glands / Q000503:physiopathology; D010758:Phosphorus / Q000097:blood; D017410:Practice Guidelines as Topic; D012955:Societies, Medical
chemical_list: D010758:Phosphorus; D002118:Calcium